Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Eri Oguma"'
Autor:
Rishu Takimoto, Takashi Kamigaki, Takuji Gotoda, Toshimi Takahashi, Sachiko Okada, Hiroshi Ibe, Eri Oguma, Shigenori Goto
Publikováno v:
Journal of Medical Case Reports, Vol 15, Iss 1, Pp 1-8 (2021)
Abstract Background Blocking the programmed death 1 pathway by immune checkpoint inhibitors induces dramatic antitumor activity in patients with malignant tumors. However, the clinical response to immune checkpoint inhibitors remains limited owing to
Externí odkaz:
https://doaj.org/article/3f53ba5655b64d9ca3fc37d75d622aee
Publikováno v:
Anticancer Research. 41:4133-4141
Background/aim Advanced/recurrent breast cancer (ARBC) still has a poor prognosis; therefore, new treatment strategies are required. In this retrospective study, we aimed to investigate the efficacy of immune-cell therapy using T lymphocytes activate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94cc000c4b4daa3b0572c30ab73ff4fc
https://doi.org/10.21873/anticanres.15216
https://doi.org/10.21873/anticanres.15216
Publikováno v:
Anticancer research. 42(8)
The efficacy of adjuvant systemic therapy after surgical resection remains unsatisfactory; therefore, a new treatment strategy is required. We aimed to examine the efficacy of adjuvant immune-cell therapy using activated T lymphocytes with or without
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61d5080606f78cb7ff920391c97a5c45
https://pubmed.ncbi.nlm.nih.gov/35896218
https://pubmed.ncbi.nlm.nih.gov/35896218
Autor:
Tomoharu Miyashita, Sachiko Okada, Keiko Naitoh, Eri Oguma, Takashi Kamigaki, Kaori Makita, Hiroshi Ibe, Katsuro Tomita, Kosei Yasumoto, Shigenori Goto, Rishu Takimoto, Eishiro Mizukoshi
Publikováno v:
Cytotherapy. 22:329-336
Background aims Activated γδT cells have been shown to exhibit cytotoxicity against tumor cells. However, the efficacy of γδT cell immunotherapy for a large number of patients with solid tumors remains unclear. In this study, we examined the effi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5382e0142a1d9e061e6c4bdba8df4c73
https://doi.org/10.1016/j.jcyt.2020.02.008
https://doi.org/10.1016/j.jcyt.2020.02.008
Autor:
Rishu Takimoto, Shigenori Goto, Eriko Matsuda, Keiko Naitoh, Sachiko Okada, Hiroshi Ibe, Eri Oguma, Takashi Kamigaki, Kaori Makita
Publikováno v:
Anticancer Research. 39:4525-4532
Background/aim In this retrospective study, we aimed to investigate the efficacy of immune-cell therapy using T lymphocytes activated in vitro with or without dendritic cells vaccination (DCs), in combination with 1st-line chemotherapies in terms of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f41c2a401ba24e6176b1677dc379223b
https://doi.org/10.21873/anticanres.13629
https://doi.org/10.21873/anticanres.13629
Autor:
Toshimi Takahashi, Shigenori Goto, Sachiko Okada, Rishu Takimoto, Hiroshi Ibe, Takuji Gotoda, Eri Oguma, Takashi Kamigaki
Publikováno v:
Journal of Medical Case Reports, Vol 15, Iss 1, Pp 1-8 (2021)
Journal of Medical Case Reports
Journal of Medical Case Reports
Background Blocking the programmed death 1 pathway by immune checkpoint inhibitors induces dramatic antitumor activity in patients with malignant tumors. However, the clinical response to immune checkpoint inhibitors remains limited owing to the pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7fde802b50c535a17ee192145b5d2aa
https://doi.org/10.1186/s13256-020-02634-z
https://doi.org/10.1186/s13256-020-02634-z
Autor:
Keiko Naitoh, Shigenori Goto, Eriko Matsuda, Hiroshi Ibe, Eri Oguma, Takashi Kamigaki, Kaori Makita, Sachiko Okada, Rishu Takimoto
Publikováno v:
Anticancer Research. 38:4353-4360
BACKGROUND/AIM The past 17 years, immune-cell therapy has been administered to 990 patients with advanced or recurrent pancreatic adenocarcinoma and 50 patients with curatively resected pancreatic adenocarcinoma. MATERIALS AND METHODS The correlation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1f730313f502859a664fdbe12f0788a
https://doi.org/10.21873/anticanres.12736
https://doi.org/10.21873/anticanres.12736
Autor:
Keiko Naitoh, Eriko Matsuda, Hiroshi Ibe, Sachiko Okada, Shigenori Goto, Rishu Takimoto, Eri Oguma, Takashi Kamigaki, Kaori Makita
Publikováno v:
Anticancer Research. 37
BACKGROUND Conventional therapy for advanced gastric cancer (GC) has limited survival benefits. In this retrospective study, we aimed to investigate the efficacy of immune-cell therapy, using in vitro-activated T-lymphocytes with and without dendriti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2273ceb1ffb8b58ca50c0ff557d12b6
https://doi.org/10.21873/anticanres.11778
https://doi.org/10.21873/anticanres.11778
Autor:
Takashi, Kamigaki, Hiroshi, Ibe, Sachiko, Okada, Eriko, Matsuda, Masanori, Tanaka, Eri, Oguma, Yoshihiro, Kinoshita, Shun, Ogasawara, Atsuko, Ono, Kaori, Makita, Keiko, Naitoh, Shigenori, Goto
Publikováno v:
Anticancer research. 35(8)
We evaluated the immunological status of patients with various solid tumors by flow cytometry of immune cell populations and their frequencies in peripheral blood samples. The change in immunological status was also analyzed in patients given autolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::76f02dc3fb88b2552169006996a81317
https://pubmed.ncbi.nlm.nih.gov/26168498
https://pubmed.ncbi.nlm.nih.gov/26168498